Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents $ 2,487 $ 1,769
Accounts receivable, net 198 2,150
Inventories, net 7,087 7,971
Investment in marketable securities   27,929
Prepaid expenses and other current assets 1,485 1,402
Total current assets 11,257 41,221
Property and equipment, net 120 151
Equity method investment 15,925 13,325
Right of use assets 4,072 4,474
Investment in convertible bond 27,866  
Other assets 296 285
Total assets 59,536 59,456
CURRENT LIABILITIES    
Accounts payable and accrued expenses 7,460 11,498
Operating lease liabilities, current portion 1,143 991
Other current liabilities 2,706 5,748
Revolving line of credit from related party 800 600
Warrant derivative liabilities 1,071 38
Notes payable 4,588 3,749
Notes payable to related parties 134 193
Convertible debentures, net of discount 5,480 7,015
Convertible notes payable, net of discount   2,995
Total current liabilities 23,382 32,827
Operating lease liabilities, less current portion 3,470 3,932
Other long-term liabilities 34,470 33,750
Notes payable, less current portion 222  
Convertible notes payable 3,150  
Total liabilities 64,694 70,509
STOCKHOLDERS’ DEFICIT    
Preferred stock — par value $0.001 per share, 15,000,000 shares authorized, none issued and outstanding
Common stock — par value $0.001 per share, 250,000,000 shares authorized, shares 48,987,189 and 48,471,446 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively 49 48
Additional paid-in capital 218,728 215,207
Accumulated other comprehensive Income (loss) 1,144 (79)
Accumulated deficit (225,079) (226,229)
Total stockholders’ deficit (5,158) (11,053)
Total liabilities & stockholders’ deficit $ 59,536 $ 59,456